domingo, 18 de mayo de 2025

In Price Negotiations, Medicare Should Reassess How It Determines A ‘Qualifying Single Source Drug’ T. Joseph Mattingly II

https://www.healthaffairs.org/content/forefront/qualifying-single-source-drug-determination-medicare-drug-price-negotiation

No hay comentarios: